Millennium Institute on Immunology and Immunotherapy
@imii.cl
Scientific and technological research at the frontiers of knowledge
Pinned
Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial - Nature Communications
The authors report a trial subset analysis of the immune responses induced by two inactivated quadrivalent influenza vaccines (QIVs): Sinovac QIV and Vaxigrip-Tetra™. Both vaccines elicit robust humor...
bit.ly
Researchers from the IMII are participating in a phase 3 study accepted in @natcomms.nature.com, which evaluated two quadrivalent vaccines against influenza viruses and compared humoral and cellular responses, showing differences in antibodies and T cells.
📄 bit.ly/44kuOCL
📄 bit.ly/44kuOCL
On December 2-3, Dr. Susan Bueno and Dr. Hernán Peñaloza visited the @lji.org La Jolla Institute for Immunology in San Diego to advance studies on T cell-mediated immune responses in infections and vaccination.
IMII fortalece colaboración científica con La Jolla Institute for Immunology en visita a Estados Unidos - IMII - Instituto Milenio en Inmunología e Inmunoterapia :: Millennium Institute on Immunology ...
Entre el 2 y el 3 de diciembre, la Dra. Susan Bueno y el Dr. Hernán Peñaloza, investigadores del Instituto Milenio en Inmunología e Inmunoterapia (IMII) y académicos de la P. Universidad Católica de C...
imii.cl
December 23, 2025 at 1:09 AM
On December 2-3, Dr. Susan Bueno and Dr. Hernán Peñaloza visited the @lji.org La Jolla Institute for Immunology in San Diego to advance studies on T cell-mediated immune responses in infections and vaccination.
Today, the "100 Young Leaders 2025" award ceremony takes place, an initiative led by El Mercurio and Universidad Adolgo Ibáñez.
Dr. Aracelly Gaete and Dr. Hernán Peñaloza, researchers at the IMII, were recognized for their contributions to virology and immunology.
Dr. Aracelly Gaete and Dr. Hernán Peñaloza, researchers at the IMII, were recognized for their contributions to virology and immunology.
Dra. Aracelly Gaete y Dr. Hernán Peñaloza son destacados entre los “100 Jóvenes Líderes” 2025 por sus aportes en virología e inmunología - IMII - Instituto Milenio en Inmunología e Inmunoterapia :: Mi...
El Mercurio y la Universidad Adolfo Ibáñez anunciaron recientemente la lista “100 Jóvenes Líderes” 2025, que reconoce a jóvenes menores de 35 años por sus contribuciones en innovación, ciencia y lider...
imii.cl
December 18, 2025 at 9:37 PM
Today, the "100 Young Leaders 2025" award ceremony takes place, an initiative led by El Mercurio and Universidad Adolgo Ibáñez.
Dr. Aracelly Gaete and Dr. Hernán Peñaloza, researchers at the IMII, were recognized for their contributions to virology and immunology.
Dr. Aracelly Gaete and Dr. Hernán Peñaloza, researchers at the IMII, were recognized for their contributions to virology and immunology.
Dr. Alexis Kalergis, director of the IMII and UC academic, participated in the II Regional WHO/PAHO/MPP Meeting on mRNA Vaccine R&D held in Brasília. He addressed the challenges involved in strengthening innovation, scientific collaboration, and technology transfer.
Reunión regional de la OMS y la OPS reúne en Brasil a expertos para avanzar en el desarrollo de vacunas basadas en mRNA - IMII - Instituto Milenio en Inmunología e Inmunoterapia :: Millennium Institut...
Con el objetivo de fortalecer la preparación sanitaria regional y avanzar en tecnologías de mRNA, la Organización Mundial de la Salud (OMS), la Organización Panamericana de la Salud (OPS) y Medicines ...
bit.ly
December 11, 2025 at 8:44 PM
Dr. Alexis Kalergis, director of the IMII and UC academic, participated in the II Regional WHO/PAHO/MPP Meeting on mRNA Vaccine R&D held in Brasília. He addressed the challenges involved in strengthening innovation, scientific collaboration, and technology transfer.
Researchers from the IMII are participating in a phase 3 study accepted in @natcomms.nature.com, which evaluated two quadrivalent vaccines against influenza viruses and compared humoral and cellular responses, showing differences in antibodies and T cells.
📄 bit.ly/44kuOCL
📄 bit.ly/44kuOCL
Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial - Nature Communications
The authors report a trial subset analysis of the immune responses induced by two inactivated quadrivalent influenza vaccines (QIVs): Sinovac QIV and Vaxigrip-Tetra™. Both vaccines elicit robust humor...
bit.ly
December 11, 2025 at 7:36 PM
Researchers from the IMII are participating in a phase 3 study accepted in @natcomms.nature.com, which evaluated two quadrivalent vaccines against influenza viruses and compared humoral and cellular responses, showing differences in antibodies and T cells.
📄 bit.ly/44kuOCL
📄 bit.ly/44kuOCL
On October 20, Catalina Andrade, from Dr. Alexis Kalergis’s Biomedical Molecular Immunology Laboratory, successfully defended her doctoral thesis “Immunomodulation against respiratory viruses is key to preventing neurological sequelae,” receiving the highest grade.
November 5, 2025 at 12:17 AM
On October 20, Catalina Andrade, from Dr. Alexis Kalergis’s Biomedical Molecular Immunology Laboratory, successfully defended her doctoral thesis “Immunomodulation against respiratory viruses is key to preventing neurological sequelae,” receiving the highest grade.
The IMII concluded the activities of the PME project “Food and Immunity Space” with a visit from students of the Instituto de Humanidades Luis Campino.
Guided by Dr. Hernán Peñaloza and his team, the students explored how food influences the immune system.
Guided by Dr. Hernán Peñaloza and his team, the students explored how food influences the immune system.
November 4, 2025 at 7:15 PM
The IMII concluded the activities of the PME project “Food and Immunity Space” with a visit from students of the Instituto de Humanidades Luis Campino.
Guided by Dr. Hernán Peñaloza and his team, the students explored how food influences the immune system.
Guided by Dr. Hernán Peñaloza and his team, the students explored how food influences the immune system.
During August and September, the IMII carried out activities in Temuco and Santiago to bring the science of nutrition and immunity closer to high school students.
Talks, workshops, and experiments showed how nutrition can strengthen the immune system and inspire future scientific careers.
Talks, workshops, and experiments showed how nutrition can strengthen the immune system and inspire future scientific careers.
November 4, 2025 at 3:37 PM
During August and September, the IMII carried out activities in Temuco and Santiago to bring the science of nutrition and immunity closer to high school students.
Talks, workshops, and experiments showed how nutrition can strengthen the immune system and inspire future scientific careers.
Talks, workshops, and experiments showed how nutrition can strengthen the immune system and inspire future scientific careers.
On October 9th, the IMII and the HPI organized the seminar 'New Era in Vaccines' in Athens. Drs. Alexis Kalergis, Susan Bueno, Pablo González, Hernán Peñaloza, and Mario Calvo discussed advances in vaccines and clinical trials, fostering Chile-Greece cooperation.
October 24, 2025 at 6:45 PM
On October 9th, the IMII and the HPI organized the seminar 'New Era in Vaccines' in Athens. Drs. Alexis Kalergis, Susan Bueno, Pablo González, Hernán Peñaloza, and Mario Calvo discussed advances in vaccines and clinical trials, fostering Chile-Greece cooperation.
From October 1 to 3, the IMII held the SIS 2025: 'Communicating Immunology' at the UC, with more than 1,500 participants. The event addressed vaccines, immunotherapy, and scientific communication, establishing itself as a key player in biomedical research.
October 24, 2025 at 6:36 PM
From October 1 to 3, the IMII held the SIS 2025: 'Communicating Immunology' at the UC, with more than 1,500 participants. The event addressed vaccines, immunotherapy, and scientific communication, establishing itself as a key player in biomedical research.